Literature DB >> 33206224

Calcified constrictive pericarditis resulting in tamponade in a patient with systemic lupus erythematosus.

Antigone Pieta1, Eleftherios Pelechas1, Nafsika Gerolymatou1, Paraskevi V Voulgari1, Alexandros A Drosos2.   

Abstract

Systemic lupus erythematosus (SLE) is a chronic autoimmune disease with multiorgan involvement, including heart. Pericarditis-the most common cardiac manifestation-occurs in up to 50% of cases, resulting in positive treatment outcomes. Rarely, it evolves to hazardous complications. A 50-year-old woman with SLE in clinical remission, receiving hydroxychloroquine 400 mg/day, presented to us with severe chest pain and low-grade fever. Physical examination revealed a friction rub and decreased breath sounds at the right lung base. Laboratory evaluation demonstrated leukopenia, thrombocytopenia, low C4 levels, and high acute phase reactants. Chest X-ray exhibited cardiomegaly, calcified pericardium, and right pleural effusion, confirmed by CT scan. PPD skin test and IGRA were both negative. Pericardial fluid, blood, and urine cultures for bacteria and fungi, as well as Gram and Ziehl-Neelsen stains were negative. Serological tests for viruses were also negative. The patient was diagnosed with calcified constrictive pericarditis (CP) due to SLE. She was treated with cyclophosphamide and methylprednisolone pulses, without improvement. Her clinical condition deteriorated, developing signs and symptoms compatible with cardiac tamponade (TMP), which was confirmed by Doppler echocardiography. The patient underwent pericardiectomy. A dramatic response was noted and she was discharged with prednisone 50 mg/day and azathioprine 100 mg/day. Thus, we review and discuss the relevant literature of SLE cases with CP or TMP. When an SLE patient presents with CP, infectious causes should be excluded first. To the best of our knowledge, this is the only case of SLE and calcified CP leading to TMP, hence physicians should be aware of this complication.

Entities:  

Keywords:  Calcified pericarditis; Cardiac manifestations; Cardiac tamponade; Constrictive pericarditis; SLE

Year:  2020        PMID: 33206224     DOI: 10.1007/s00296-020-04747-6

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  45 in total

1.  Gender and age differences in systemic lupus erythematosus. A study of 489 Greek patients with a review of the literature.

Authors:  P V Voulgari; P Katsimbri; Y Alamanos; A A Drosos
Journal:  Lupus       Date:  2002       Impact factor: 2.911

2.  CONSTRICTIVE PERICARDITIS COMPLICATING DISSEMINATED LUPUS ERYTHEMATOSUS.

Authors:  P M YURCHAK; S A LEVINE; R GORLIN
Journal:  Circulation       Date:  1965-01       Impact factor: 29.690

3.  Transient constrictive pericarditis in systemic lupus erythematous.

Authors:  Ja Young Oh; Sung-A Chang; Yeon Hyeon Choe; Duk-Kyung Kim
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2012-03-28       Impact factor: 6.875

4.  Rapid development of constrictive pericarditis in a patient with systemic lupus erythematosus.

Authors:  R H Starkey; B H Hahn
Journal:  Chest       Date:  1973-03       Impact factor: 9.410

5.  [Constrictive pericarditis as a serious and rare presentation of systemic lupus erythematosus: Report of one case].

Authors:  Nicole Lustig; Pablo Florenzano; Luis Manuel Sanhueza; Ximena Cid; Germán Ramos; Natalie Thone; Demian A Fullerton
Journal:  Rev Med Chil       Date:  2014-08       Impact factor: 0.553

6.  2015 ESC Guidelines for the diagnosis and management of pericardial diseases: The Task Force for the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology (ESC)Endorsed by: The European Association for Cardio-Thoracic Surgery (EACTS).

Authors:  Yehuda Adler; Philippe Charron; Massimo Imazio; Luigi Badano; Gonzalo Barón-Esquivias; Jan Bogaert; Antonio Brucato; Pascal Gueret; Karin Klingel; Christos Lionis; Bernhard Maisch; Bongani Mayosi; Alain Pavie; Arsen D Ristic; Manel Sabaté Tenas; Petar Seferovic; Karl Swedberg; Witold Tomkowski
Journal:  Eur Heart J       Date:  2015-08-29       Impact factor: 29.983

7.  Systemic lupus erythematosus presenting as effuso-constrictive pericarditis.

Authors:  S R McMechan; B M McClements; P P McKeown; S W Webb; A A Adgey
Journal:  Postgrad Med J       Date:  1995-10       Impact factor: 2.401

8.  Immune complexes in the pericardial fluid in systemic lupus erythematosus.

Authors:  F P Quismorio
Journal:  Arch Intern Med       Date:  1980-01

9.  Heart failure with complete recovery in a patient with systemic lupus erythematosus.

Authors:  Konstantinos Lampropoulos; Dimitrios Kotsas; Themistoklis Iliopoulos
Journal:  Reumatologia       Date:  2015-04-10

10.  2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus.

Authors:  Martin Aringer; Karen Costenbader; David Daikh; Ralph Brinks; Marta Mosca; Rosalind Ramsey-Goldman; Josef S Smolen; David Wofsy; Dimitrios T Boumpas; Diane L Kamen; David Jayne; Ricard Cervera; Nathalie Costedoat-Chalumeau; Betty Diamond; Dafna D Gladman; Bevra Hahn; Falk Hiepe; Søren Jacobsen; Dinesh Khanna; Kirsten Lerstrøm; Elena Massarotti; Joseph McCune; Guillermo Ruiz-Irastorza; Jorge Sanchez-Guerrero; Matthias Schneider; Murray Urowitz; George Bertsias; Bimba F Hoyer; Nicolai Leuchten; Chiara Tani; Sara K Tedeschi; Zahi Touma; Gabriela Schmajuk; Branimir Anic; Florence Assan; Tak Mao Chan; Ann Elaine Clarke; Mary K Crow; László Czirják; Andrea Doria; Winfried Graninger; Bernadett Halda-Kiss; Sarfaraz Hasni; Peter M Izmirly; Michelle Jung; Gábor Kumánovics; Xavier Mariette; Ivan Padjen; José M Pego-Reigosa; Juanita Romero-Diaz; Íñigo Rúa-Figueroa Fernández; Raphaèle Seror; Georg H Stummvoll; Yoshiya Tanaka; Maria G Tektonidou; Carlos Vasconcelos; Edward M Vital; Daniel J Wallace; Sule Yavuz; Pier Luigi Meroni; Marvin J Fritzler; Ray Naden; Thomas Dörner; Sindhu R Johnson
Journal:  Arthritis Rheumatol       Date:  2019-08-06       Impact factor: 15.483

View more
  1 in total

1.  Clinical Efficacy of Gandakang Tablets plus Methylprednisolone in Patients with Systemic Lupus Erythematosus.

Authors:  Min Wang; Guoquan Li; Shanzhi Wang; Feng Ye; Yanni Huang; Huanan Wang; Feng Guo
Journal:  Evid Based Complement Alternat Med       Date:  2022-04-28       Impact factor: 2.650

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.